Surface Oncology, Inc. 4/A SEC Filings

Filed On	Filing
11 Mar 2021	Form 4/A: Ross Robert W., Chief Medical Officer Granted 484,280 Stock Option (Right to Buy)
21 Dec 2020	Form 4/A: Grayzel David S., Director Sold 1,700,000 shares ($13.8M)
21 Dec 2020	Form 4/A: Atlas Venture Fund IX, L.p., 10% owner and 2 others Sold 1,700,000 shares ($13.8M)

Comments